Prevalence of candidiasis among female patients attending Federal Medical Centre Owerri, Imo State, Nigeria
DOI:
https://doi.org/10.30574/gscarr.2021.9.1.0212Keywords:
Vaginosis, Candida albicans, Underwears, Pregnant women, NigeriaAbstract
In this study, the prevalence and associated risk factors of vaginal candidiasis among female patients attending the Federal Medical Centre, Owerri was investigated. High Vaginal Swabs (HVS) specimens were collected, cultured and C. albicans identified. The overall prevalence rate of vaginal candidiasis was 28.3%, with the highest rate of 33.3% observed among the age group 26-30years, while the lowest prevalence (17.1%) was among ages 31-45 years. Based on the nature of underwear, those who wore silk and very tight underwear recorded the highest prevalence (34.5% and 77.8%, respectively) while those who wore nylon and loose underwears had the least prevalence (23.1% and 24.2%, respectively). By level of education, primary school leavers had the highest prevalence (50%) while graduates had the lowest prevalence (23.9%). Those who had history of STI and those with vaginal discharge/discomfort had high prevalence of 30.8% and 30.1%, respectively. The study revealed the prevalence of vaginal candidiasis among general study subjects to be 28.3%; 34 out of 120, which was considerably higher than that of non-candidiasis; 86 out of 120. Low income, sexual activity, tight underwears, previous history of STI, ignorance, as well as poor personal hygiene have been implicated as possible risk factors. Efforts should therefore be made to educate females on the subject from time to time and access to quality social amenities, health care services, prompt diagnosis and treatment of STI and vaginosis should be improved upon. Microbiological analysis of HVS for all pregnant women during their first antenatal visit is also recommended.
Metrics
References
Foxman B, Barlow R, D’arcy H, Gillespie B, Sobel JD. Candida vaginitis: Self-reported incidence and associated costs. Sex Transmission of Diseases. 2008; 27: 230-235.
Emeribe AU, Nasir IA, Onyia J, Ifunanya AL. Prevalence of Vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria. Research and Reports in Tropical Medicine. 2015; 6: 37-42.
Al-Ahmadey ZZ, Mohamed SA. Vulvovaginal candidiasis: Agents and its virulence factors. Microbiology Research International. 2014; 2: 28-37.
Ferrer J. Vaginal candidiasis epidemiological and etiological factors. International Journal of Gynecology and Obstetrics. 2000; 200-203.
Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK. Vulvovaginal candidiasis: Clinical manifestations, risk factors, management algorithm. Obstetrics Gynecology. 2004; 92: 757-765.
Rathod SD, Klausner JD, Krupp K, Reingold AL, Madhivanan P. Epidemiologic features of Vulvovaginal candidiasis among reproductive-age women in India. Infectious Diseases in Obstetrics and Gynecology. 2012; 1: 1-5.
Klufio CA, Amoa AB, Delamare O, Hombhanje M, Kariwiga G, Igo J. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic. Papua New Guinea Medical Journal. 1995; 38: 163-71.
Toua V, Djaouda M, Gaké B, Menye DE, Christie EA, Tambe E, Akindoh VV, Njiné T. Prevalence of Vulvovaginal candidiasis amongst pregnant women in Maroua (Cameroon) and the sensitivity of Candida albicans to extracts of six locally used antifungal plants. International Research Journal of Microbiology. 2013; 4: 89-97.
Umeh EU, Umeakanne BI. HIV/vaginal Candida co-infection: Risk factors in women. Journal of Microbiology and Antimicrobials. 2010; 2: 30-35.
Ishaku MJ, Yami AL, Zamfara, KA, Nganjiwa SG. The prevalence of Vaginal Candida colonization among female students in Bingham University. British Microbiology Research Journal. 2016; 12: 1-7.
Akingbade OA, Akinjinmi AA, Awoderu OB, Okerentugba PO, Okonko IO. Prevalence of Candida albicans amongst women attending health Centres in Abeokuta, Ogun State, Nigeria. New York Science Journal. 2013; 6: 53-59.
Sobel JD, Faros OD, Forces RW, Foxman B, Ledge WJ, Nyirjesy PR, Foxman P, Summer PR. Vulvovaginal candidiasis: Epidemiological, diagnostic and therapeutic considerations. American Journal of Obstetrics and Gynecology. 1998; 178(2): 203-211.
Berkow R, Beers M, Fletcher AJ, Chir B, Bogin R. The Merck Manual of Medical Information. Home Edition. Merck Manual of Diagnosis and Therapy M.D. 2001.
Ezeigbo OR, Anolue FC, Nnadozie IA. Vaginal Candidiasis Infection among Pregnant Women in Aba, Abia State, Nigeria. British Journal of Medicine & Medical Research. 2015; 9(3): 1-6.
Alo MN, Anyim C, Onyebuchi AK, Okonkwo EC. Prevalence of asymptomatic co-Infection of candidiasis and vaginal trichomoniasis among pregnant women in Abakaliki, South-Eastern Nigeria. J Nat Sci Res. 2012; 2(7): 87–91.
Nwadioha SI, Egah DZ, Alao OO, Iheanacho E. Risk factors for vaginal candidiasis among women attending primary health care centers of Jos, Nigeria. Journal of Clinical Medical Research. 2010; 2(7): 110-113.
Yadav K, Prakash S. Prevalence of Vulvovaginal Candidiasis in Pregnancy. Global Journal of Medicine and Medical Sciences. 2016; 4(1): 108-116.
Jombo GT, Opajobi SO, Egah DZ, Banwat EB, Denen AP. Symptomatic vulvovaginal candidiasi and genital colonization by Candida species in Nigeria. Journal of Public Health Epidemiology. 2010; 2(6): 147-151.
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.